A novel apolipoprotein E mutation (p.Arg150Cys) in a Chinese patient with lipoprotein glomerulopathy
Open accessAbstract
To the Editor: Lipoprotein glomerulopathy (LPG) is an uncommon inherited renal disease characterized by lipoprotein thrombi in the markedly dilated capillary lumina of affected glomeruli, high plasma concentrations of apolipoprotein E (apoE), and proteinuria.[1] It mainly affects people of Japanese and Chinese origin, and approximately 117 cases have been reported to date.[2,3] Several genetic studies have demonstrated that APOE gene mutations may lead to the development of LPG;[4-6] however, conflicting published evidence has found that some patients with APOE variants were unaffected.[7] Thus, further studies are needed to examine the role of APOE mutations in the pathogenesis of LPG. This study investigated a novel point mutation in the APOE gene in a family with one LPG patient and an asymptomatic carrier of the same APOE variant. This study was conducted in accordance with the declaration of Helsinki and was approved by the Ethics Committee of Shenzhen University. Written informed consent was obtained from all participants. A 21-year-old Chinese woman was in good health until December 2016, when during a 3-month-antenatal examination, it was determined that she had moderate proteinuria. Throughout her pregnancy, she had moderate to severe proteinuria (up to 5.2 g/day). Four months after giving birth to a healthy baby girl, she was admitted to the hospital. She had no known family history of renal disease or lipidosis. The patient was 162 cm tall and weighed 55 kg. Her blood pressure was 115/77 mmHg. She did not have pedal edema. Her urinary protein excretion was 4.0 g/day, her glomerular filtration rate was 145 mL/min, and her urine sediment contained blood cells (5–8 red blood cells/high-power field). Twenty-four-hour urine protein was 2.4 g. Other laboratory examinations revealed white blood cell count: 5.08 × 109/L, hemoglobin: 119 g/L, platelet count: 146 × 109/L, albumin: 38 g/L, blood urea nitrogen: 4.2 mmol/L, serum creatinine: 45.8 μmol/L, uric acid: 525.6 μmol/L, total cholesterol (TC): 8.53 mmol/L, low-density lipoprotein cholesterol (LDL-C): 6.44 mmol/L, high-density lipoprotein cholesterol: 1.34 mmol/L, triglycerides (TG): 1.56 mmol/L, and fasting blood glucose: 4.46 mmol/L. Hepatitis B surface antigen, anti-hepatitis C antibody, and antinuclear antibody tests were all negative. Complement levels were normal. An abdominal ultrasound showed that her renal shape and size were normal, but marked splenomegaly was observed. A percutaneous renal biopsy was performed for definitive diagnosis. By light microscopy, a total of 21 glomeruli were evaluated, 2 of which showed global sclerosis. Glomerular volume was slightly increased and was distorted by markedly dilated diffuse capillaries containing pale-staining thrombi in a layered structure, and mesangial cells and stroma showed mild to moderate proliferation. A few of the glomeruli had small synechiae between the glomerular capillaries and Bowman capsules [Figure 1A]. Staining with oil red O showed a number of lipid droplets in the glomerular capillary lumina [Figure 1B]. Foam cells were not present in either the glomeruli or the tubulointerstitium. There was interstitial edema with focal inflammatory cellular infiltration, mild and limited interstitial fibrosis, and tubular atrophy. Routine fluorescent microscopy showed trace to 1+ linear deposits of immunoglobulin M (not shown). Other immunoglobulins, C3, C4, and C1q were not detected. Strong, segmental staining for both apoE [Figure 1D] and apoB (not shown) was observed in the capillary lumina. One glomerulus was examined by electron microscopy. Almost all of the dilated capillary lumina were occluded by numerous lipid granules and lamellate vacuoles [Figure 1C].Figure 1: Glomerular findings from renal biopsy specimens in a 21-year-old Chinese LPG patient (II-1, proband). Light microscopy showed that the capillary lumina were dilated by amorphous lipoprotein thrombi (A; periodic Schiff-methenamine staining, × 400), and massive pale-stained deposits were observed in the capillary lumen (B; Oil-red-O staining, × 400). Electron micrograph showed Lamellate thrombi occupy the capillary lumen (C, × 4000). Segmental immunofluorescent stainings of apoE were present in the glomeruli (D, × 400). (E) Nucleotide sequence of a segment of exon 4 in the APOE gene for both alleles of the proband (patient II-1). The lower panel shows the allele containing a nucleotide C to T point mutation at nucleotide 208 in codon 150 of the gene. (F) Family tree of patients with LPG. LPG: Lipoprotein glomerulopathy; apoE: apolipoprotein E.In this study, exon 4 of the APOE gene was analyzed in 4 separate individuals by DNA sequencing. Genomic DNA was extracted from blood using the DNA Blood Magen Kit (Magen, Guangzhou, China) and 1 mL of the extraction was used as a template for PCR amplification. Exon 4 of the APOE gene was amplified using PCR 2xTaq Master Mix (Vazyme, Nanjing, China). The primers for exon 4 were as follows:
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
APOE (p.Arg150Cys) is correctly identified as APOE (Arg150Cys), the same variant as APOE Modena (Arg150Cys).
“Meanwhile, APOE (p.Arg150Cys)92) is correctly identified as APOE (Arg150Cys), the same variant as APOE Modena (Arg150Cys)78).”
From Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features (2025) · cites this paper as [92]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Lipoprotein Glomerulopathy: Glomerular Lipoprotein Thrombi in a Patient With Hyperlipoproteinemia
Saito, T., Sato, H., Kudo, K.-I., Oikawa, S.-I., Shibata, T., Hara, Y., Yoshinaga, K., & Sakaguchi, H. (1989) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(89)80134-9 · Cited by 148 · see citing works
Wu, H., Yang, Y., & Hu, Z. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.41996 · Cited by 24 · see citing works
Flagged first, then by citations
Research works printed but not linked: 7
- [2]Saito T Matsunaga A Oikawa S Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases. Am J Kidney Dis 2006; 47: 199– 211. doi: 10.1053/j.ajkd.2005.10.017. 16431249 · DOI · Paper page
- [4]Hu Z Huang S Wu Y Liu Y Liu X Su D Hereditary features, treatment, and prognosis of the lipoprotein glomerulopathy in patients with the APOE Kyoto mutation. Kidney Int 2014; 85: 416– 424. doi: 10.1038/ki.2013.335. 24025644 · DOI · Paper page
- [5]Hagiwara M Yamagata K Matsunaga T Arakawa Y Usui J Shimizu Y A novel apolipoprotein E mutation, ApoE Tsukuba (Arg 114 Cys), in lipoprotein glomerulopathy. Nephrol Dial Transplant 2008; 23: 381– 384. doi: 10.1093/ndt/gfm735. 17967799 · DOI · Paper page
- [6]Kinomura M Sugiyama H Saito T Matsunaga A Sada KE Kanzaki M A novel variant apolipoprotein E Okayama in a patient with lipoprotein glomerulopathy. Nephrol Dial Transplant 2008; 23: 751– 756. doi: 10.1093/ndt/gfm675. 18045818 · DOI · Paper page
- [7]Chen S Liu ZH Zheng JM Zhang X Li LS A complete genomic analysis of the apolipoprotein E gene in Chinese patients with lipoprotein glomerulopathy. J Nephrol 2007; 20: 568– 575. PMID: 17918142. 17918142
- [8]Luo B Huang F Liu Q Li X Chen W Zhou SF Identification of apolipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy. Am J Nephrol 2008; 28: 347– 353. doi: 10.1159/000111828. 18046082 PMC2785906 · DOI · Paper page
- [9]Tudorache IF Trusca VG Gafencu AV Apolipoprotein E - A multifunctional protein with implications in various pathologies as a result of its structural features. Comput Struct Biotechnol J 2017; 15: 359– 365. doi: 10.1016/j.csbj.2017.05.003. 28660014 PMC5476973 · DOI · Paper page
Cited by
Sorted by citations
APOE gene variants in primary dyslipidemia
Khalil, Y. A., Rabès, J.-P., Boileau, C., & Varret, M. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.05.007 · Cited by 170 · see citing works
Apolipoprotein E–related glomerular disorders
Saito, T., Matsunaga, A., Fukunaga, M., Nagahama, K., Hara, S., & Muso, E. (2020) · Kidney International · doi:10.1016/j.kint.2019.10.031 · Cited by 77 · see citing works
Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features
Matsunaga, A., & Saito, T. (2025) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.65393 · Cited by 14 · see citing works
Li, Y., Chen, J., Zou, Y., Wang, W., & Li, G. (2022) · Medicine · doi:10.1097/md.0000000000028718 · Cited by 5 · see citing works
- Authors
- Ku, M., Tao, C., Zhou, A.-A., Cheng, Y., & Wan, Q.-J.
- Affiliations
- Shenzhen University (CN)
- ORCID
- Cheng, Yuan
- Venue
- Chinese Medical Journal
- Published
- 2019-01-20
- Volume
- 132
- Issue
- 2
- Pages
- 237-239
- ISSN
- 0366-6999 (ISSN-L)
- PMC
- PMC6365261
- OpenAlex
- W2909849386
- Cited by
- 8
- References
- 2
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2022: 2 · 2021: 2 · 2019: 1
- FWCI
- 0.96
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Chinese Medical Journal (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Health and Family Planning Commission of Shenzhen Municipality
- Topics
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Keywords
- lipoprotein glomerulopathy, apolipoprotein E, novel point mutation, proteinuria, familial inheritance, Chinese patients, genetic diagnosis, pathogenesis, hyperlipidemia, hyperuricemia, hypertriglyceridemia, hypercholesterolemia
- MeSH terms
- Adult, Apolipoproteins E, Exons, Female, Humans, Kidney Diseases, Mutation, Asian People, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review